Advanced Medical Solutions Group (LON:AMS) Hits New 52-Week Low - Time to Sell?

Advanced Medical Solutions Group plc (LON:AMS - Get Free Report)'s stock price hit a new 52-week low on Tuesday . The stock traded as low as GBX 177 ($2.36) and last traded at GBX 182.80 ($2.44), with a volume of 716075 shares trading hands. The stock had previously closed at GBX 182.60 ($2.44).

Wall Street Analyst Weigh In

Separately, Berenberg Bank reiterated a "buy" rating and issued a GBX 300 ($4.00) target price on shares of Advanced Medical Solutions Group in a research note on Wednesday, March 19th.

Advanced Medical Solutions Group Stock Performance

The company's 50-day simple moving average is GBX 204.24 and its 200 day simple moving average is GBX 206.81. The stock has a market cap of £380.46 million, a P/E ratio of 34.14, a PEG ratio of 5.00 and a beta of 0.74. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01.

Advanced Medical Solutions Group (LON:AMS - Get Free Report) last issued its quarterly earnings results on Thursday, March 20th. The company reported GBX 10.65 ($0.14) EPS for the quarter. Advanced Medical Solutions Group had a return on equity of 4.57% and a net margin of 8.49%. As a group, sell-side analysts expect that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current fiscal year.

Advanced Medical Solutions Group Increases Dividend

The business also recently announced a dividend, which will be paid on Friday, June 20th. Shareholders of record on Thursday, May 29th will be paid a GBX 1.83 ($0.02) dividend. This represents a yield of 0.89%. This is a boost from Advanced Medical Solutions Group's previous dividend of $0.77. The ex-dividend date of this dividend is Thursday, May 29th. Advanced Medical Solutions Group's payout ratio is presently 38.76%.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.